Thomson reboots PDR.net with alerts

Share this article:
Thomson has relaunched its Physicians Desk Reference portal, PDR.net, adding a new messaging tool for pharma marketers to target prescribers.

The new function, dubbed Xpert Alerts, enables Thomson to segment the 226,000 prescribers in the PDR's electronic database, according to Valerie Rasines, director of product management, e-solutions.

“We're able to do the contextual marketing that pharmaceutical manufacturers are interested in,” she said. Xpert Alerts messages can aid pharma marketers in extending their physician dialogue in a medically relevant way, Rasines added.

Thomson senior director, e-solutions Valerie Berger explained, “we're not creating a spam channel here. We have a unique identifier for every physician on the database…we know when each doctor is accessing one of our Thomson channels.”

PDR information  is available in a variety of  formats and a mobile version launched recently.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...